Effectiveness and response predictive factors of erlotinib in a non-small cell lung cancer unselected European population previously treated: a retrospective, observational, multicentric study.
about
The Difference of Clinical Characteristics Between Patients With Exon 19 Deletion and Those With L858R Mutation in Nonsmall Cell Lung Cancer.Increased EHD1 in non-small cell lung cancer predicts poor survival.Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice - results from the ElderTac study.
P2860
Effectiveness and response predictive factors of erlotinib in a non-small cell lung cancer unselected European population previously treated: a retrospective, observational, multicentric study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Effectiveness and response pre ...... rvational, multicentric study.
@en
Effectiveness and response pre ...... rvational, multicentric study.
@nl
type
label
Effectiveness and response pre ...... rvational, multicentric study.
@en
Effectiveness and response pre ...... rvational, multicentric study.
@nl
prefLabel
Effectiveness and response pre ...... rvational, multicentric study.
@en
Effectiveness and response pre ...... rvational, multicentric study.
@nl
P2093
P2860
P356
P1476
Effectiveness and response pre ...... rvational, multicentric study.
@en
P2093
Adriano Giglioni
Caterina Fanizza
Fabio Petrelli
Iolanda Grappasonni
Pasquale Cioffi
Valerio Marotta
P2860
P304
P356
10.1177/1078155212465994
P50
P577
2012-12-07T00:00:00Z